Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
6.45M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$27.2M
-
Value change
-
+$7.95M
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$4.22
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q3 2025
23 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q3 2025.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.45M shares
of 127M outstanding shares and own 5.08% of the company stock.
Largest 10 shareholders include Assenagon Asset Management S.A. (4.85M shares), Wealth Dimensions Group, Ltd. (408K shares), HighMark Wealth Management LLC (293K shares), SG Americas Securities, LLC (189K shares), Hennion & Walsh Asset Management, Inc. (159K shares), LOS ANGELES CAPITAL MANAGEMENT LLC (148K shares), Voya Investment Management LLC (115K shares), Cerity Partners LLC (70.8K shares), BAILARD, INC. (42.9K shares), and CWM, LLC (39.2K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.